Renal Safety Profile of BCR-ABL Tyrosine Kinase Inhibitors in a Real-Life Setting: A Study Based on Vigibase<sup>®</sup>, the WHO Pharmacovigilance Database.

Renal Safety Profile of BCR-ABL Tyrosine Kinase Inhibitors in a Real-Life Setting: A Study Based on Vigibase^®, the WHO Pharmacovigilance Database.

Cellier, Morgane; Bourneau-Martin, Delphine; Abbara, Chadi; Crosnier, Alexandre; Lagarce, Laurence; Garnier, Anne-Sophie; Briet, Marie.

Affiliation

Cellier M; Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire d'Angers, 4 rue Larrey, 49100 Angers, France.
Bourneau-Martin D; Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire d'Angers, 4 rue Larrey, 49100 Angers, France.
Abbara C; Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire d'Angers, 4 rue Larrey, 49100 Angers, France.
Crosnier A; Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire d'Angers, 4 rue Larrey, 49100 Angers, France.
Lagarce L; Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire d'Angers, 4 rue Larrey, 49100 Angers, France.
Garnier AS; Service de Néphrologie, Centre Hospitalo-Universitaire d'Angers, 4 rue Larrey, 49100 Angers, France.
Briet M; Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire d'Angers, 4 rue Larrey, 49100 Angers, France.

Cancers (Basel) ; 15(7)2023 Mar 29.

Article in En | MEDLINE | ID: mdl-37046701